Compare · EKSO vs LRCX
EKSO vs LRCX
Side-by-side comparison of Ekso Bionics Holdings Inc. (EKSO) and Lam Research Corporation (LRCX): market cap, price performance, sector, and recent activity on the wire.
Summary
- EKSO operates in Industrials, while LRCX operates in Technology - the two are in different parts of the market.
- LRCX is the larger of the two at $347.22B, about 8257.7x EKSO ($42.0M).
- EKSO has been more active in the news (24 items in the past 4 weeks vs 4 for LRCX).
- LRCX has more recent analyst coverage (25 ratings vs 0 for EKSO).
- Company
- Ekso Bionics Holdings Inc.
- Lam Research Corporation
- Price
- -
- -
- Market cap
- $42.0M
- $347.22B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1984
- News (4w)
- 24
- 4
- Recent ratings
- 0
- 25
Ekso Bionics Holdings Inc.
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation and OttoBock Healthcare Product GmbH. The company was founded in 2005 and is headquartered in Richmond, California.
Lam Research Corporation
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.
Latest EKSO
- SEC Form DEFA14A filed by Ekso Bionics Holdings Inc.
- SEC Form 8-K filed by Ekso Bionics Holdings Inc.
- ChronoScale Reports Fiscal First Quarter 2027 Results
- SEC Form 10-Q filed by Ekso Bionics Holdings Inc.
- SEC Form EFFECT filed by Ekso Bionics Holdings Inc.
- SEC Form 4 filed by Ekso Bionics Holdings Inc.
- SEC Form S-8 POS filed by Ekso Bionics Holdings Inc.
- SEC Form S-8 POS filed by Ekso Bionics Holdings Inc.
- SEC Form S-8 POS filed by Ekso Bionics Holdings Inc.
- SEC Form 8-K filed by Ekso Bionics Holdings Inc.
Latest LRCX
- Lam Research Corporation Announces September Quarter Financial Conference Call
- SEC Form DEFA14A filed by Lam Research Corporation
- SEC Form DEF 14A filed by Lam Research Corporation
- Wafer Inspection Equipment Market Growth — Why AI Chip Production Is Driving Demand
- President and CEO Archer Timothy exercised 30,000 shares at a strike of $30.03 and sold $9,577,800 worth of shares (30,000 units at $319.26) as part of a pre-agreed trading plan (SEC Form 4)
- Director Mayer Bethany sold $3,007,970 worth of shares (9,557 units at $314.74) (SEC Form 4)
- Senior Vice President Varadarajan Seshasayee sold $17,406,370 worth of shares (59,750 units at $291.32) as part of a pre-agreed trading plan and exercised 39,750 shares at a strike of $39.25, decreasing direct ownership by 9% to 205,546 units (SEC Form 4)
- Chief Legal Officer Harter Ava sold $1,512,300 worth of shares (5,000 units at $302.46) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 42,462 units (SEC Form 4)
- Lam Research Announces Retirement of Michael R. Cannon and Sohail U. Ahmed from Board of Directors
- Lam Research Corporation filed SEC Form 8-K: Leadership Update